LMAT
Lemaitre Vascular Inc
NASDAQ · Health Care
$87.42
+0.43 (+0.49%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 218.97M | 194.64M | 735.42M | 688.78M | 823.96M |
| Net Income | 43.86M | 35.09M | 82.00M | 87.65M | 120.31M |
| EPS | — | — | — | — | — |
| Profit Margin | 20.0% | 19.0% | 11.2% | 12.7% | 14.6% |
| Rev Growth | +12.5% | +12.5% | -7.0% | +17.5% | -8.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 329.39M | 329.39M | 685.75M | 832.61M | 742.63M |
| Total Equity | 662.22M | 662.22M | 978.19M | 1.10B | 1.03B |
| D/E Ratio | 0.50 | 0.50 | 0.70 | 0.76 | 0.72 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 57.80M | 48.81M | 159.30M | 151.37M | 185.12M |
| Free Cash Flow | — | — | 61.61M | 80.37M | 83.71M |